[1] KICKBUSCH I, LEUNG G.Response to the emerging novel coronavirus outbreak[J]. BMJ, 2020, 368: m406. [2] WU YZ, ZHOU Q, XUE Y, et al.Research progress of antivirus therapy of COVID-19: a review of clinical trials[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2020, 40(20): 2184-2190. [3] YANG P, LI J, AN W.Adverse drug reactions in 45 Patients with COVID-19[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(5): 272-275. [4] HUANG YY, HU JQ, LU HR, et al.Overview of Theory About Pathogenesis,Prevention and Treatment of Epidemic Diseases in Inner Canon of Huangdi[J]. Journal of Basic Chinese Medicine(中国中医基础医学杂志), 2020, 26(04): 421-423, 429. [5] YANG ZJ, YE L, CHEN L, et al.Treatment of COVID-19 with Qi Gui Ling mixture[J]. Acta Chinese Medicine(中医学报), 2020, 35(6): 1151-1153, 1176. [6] CUI XS, JI LM, FU H, et al.A case of novel coronavirus pneumonia patients treated by Yupingfeng powder[J]. Hubei Journal of Traditional Chinese Medicine(湖北中医杂志), 2021, 43(1): 11-13. [7] PING XH, XU HL, FU DF, et al.Clinical observation of Jiawei Yupingfeng powder combined with western medicine in the treatment of the novel coronavirus pneumonia[J]. The Medical Forum(基层医学论坛), 2021, 25(2): 149-151. [8] JIANG PF, LI SN, LIU PEI, et al.Analysis of TCM prevention and treatment schemes for COVID-19 in various regions of China[J]. Acta Chinese Medicine(中医学报), 2020, 35(4): 709-719. [9] JIANG W, JIANG SL, LIU P.Research Progress on pharmacologic effects of astragaloside IV[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2019, 37(9): 2121-2124. [10] GUO Z, ZOU J, ZHANG X, et al.Anti-inflammatory effect of total flavonoids of astragalus in vivo[J]. Progress in Veterinary Medicine(动物医学进展), 2015, 36(9): 64-66. [11] LIU SL, JIANG CX, ZHAO Y, et al.Advance in study on chemical constituents of Saposhnikovia divaricate and their pharmacological effects[J]. Chinese Traditional and Herbal Drugs(中草药), 2017, 48(10): 2146-2152. [12] GAO H, BAI CC, PANG M, et al.The new febrile disease originated in Su Wen[J]. Global Traditional Chinese Medicine, 2018, 11(11): 1740-1742. [13] JO S, KIM H, KIM S, et al.Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors[J]. Chemical Biology & Drug Design, 2019, 94(6): 2023-2030. [14] YAO YX, HE ZX, LIU XF, et al.Potential material basis of Kangbingdu Granules for treatment of coronavirus disease 2019(COVID-19) based on network pharmacology and molecular docking technology[J]. Chinese Traditional and Herbal Drugs(中草药), 2020, 51(6): 1386-1396. [15] HUAN Y.Neuroprotective effects of kaempferol against 2VO-induced chronic cerebral ischemia in rats[J]. Chinese Journal of Pharmacology and Toxicology(中国药理学与毒理学), 2016, 30(10): 1028-1029. [16] WU Y, JIN YZ, ZHANG S, et al.Effect and mechanism of wogonin on NF-κB nuclear translocation and expression in NR8383 cells infected by influenza virus[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志) , 2012, 18(18): 161-165. [17] CHEKALINA NI, SHUT SV, TRYBRAT TA, et al.Effect of quercetin on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease[J]. Wiad Lek, 2017, 70(4): 707-711. [18] LI JC.Investigation on the absorption, metabolism mechanism of wogonin[D]. Hefei: Anhui Medical University(安徽医科大学), 2010. [19] JIAN, GEORGE L, LEILEI C, et al.Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-Kappa B induced matrix metalloproteinase 9 expression[J]. Plos One, 2012, 7(9): e46264. [20] CHEN AY, WANG LQ, SHEN ZT, et al.Study of relationship between the serum levels of IL-6, IL-10, IL-17, IL-33 and radiation induced lung injury in patients with esophageal cancer[J]. Oncology Progress(癌症进展), 2019, 17(23): 2825-2829. [21] ZHANG Y, ZHOU DM, LI WEI,et al.The expression level of TNF-αin patients with painful diabetic neuropathy[J]. Chinese Journal of Laboratory Diagnosis(中国实验诊断学), 2020, 24(1): 36-40. [22] HUANG CB, WAN L, LIU J, et al.Correlation of cardiopulmonary dysfunction with activation of NF-κBp65/TNF-α and TGF-β1/Smads signaling pathways in rats with adjuvant arthritis[J]. Immunological Journal(免疫学杂志), 2014, 30(5): 382-386. [23] LIANG J, YUAN S, WANG X, et al.Attenuation of pristimerin on TNF-α-induced endothelial inflammation[J]. International Immunopharmacology, 2020, 82(5): 106326. [24] PANTEVA M, KORKAYA H, JAMEEL S.Hepatitis viruses and the MAPK pathway: is this a survival strategy?[J]. Virus Research, 2003, 92(2): 131-140. [25] LIM YX, NG YL, TAM JP, et al.Human coronaviruses: a review of virus-host interactions[J]. Diseases, 2016, 4(3): 26. [26] DESHMANE SL, AMINI S, SEN S, et al.Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins[J]. Virology Journal, 2011, 8(1): 477. [27] LI QY, FENG RF, QIAO ZL, et al.Role of hypoxia-inducible factor-1 (HIF-1) in virus infection[J]. Journal of Microbiology(微生物学杂志), 2014, 34(1): 88-91. [28] CAI J, LI HX, LIU MY, et al.Safe use of lopinavir/ritonavir for COVID-19 based on literature analysis of adverse reactions[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(6): 326-331. |